National HIV PrEP CurriculumLogo

Activity 3B. Mechanism of Action of HIV PrEP Medications

PDF Share

Learning Objective Performance Indicators

  • List the four medications approved by the U.S. Food and Drug Administration (FDA) for HIV PrEP
  • Explain the indications, dosing, and formulations, for FDA-approved HIV PrEP medications
  • Discuss the issues and recommendations for HIV PrEP usage in persons with renal impairment
  • Describe on-demand (2-1-1) HIV PrEP
  • Summarize the multiple factors to consider when choosing HIV PrEP medications for selected patients

Instructions

Watch this brief video by Dr. David Spach on the Mechanism of Action of HIV PrEP Medications (8 minutes). NOTE: this video is in the process of being updated to include the mechanism of action for the capsid inhibitor lenacapavir.
David H. Spach, MD
Editor-in-Chief
Professor of Medicine
Division of Allergy & Infectious Diseases
University of Washington
Disclosures
None

Share by e-mail

Check
-On-
Learning
Questions
The Check-on-Learning Questions are short and topic related. They are meant to help you stay on track throughout each lesson and check your understanding of key concepts.

You must be signed in to customize your interaction with these questions.

The Health Resources and Services Administration (HRSA), Department of Health and Human Services (HHS) and Centers for Disease Control and Prevention (CDC) provided financial support for this (website, PowerPoint, podcast, mini-lecture, etc.). The award provided 100% of total costs and totaled $299,994 from HRSA and $603,203 from CDC. The contents are those of the author. They may not reflect the policies of HRSA, HHS, CDC, or the U.S. Government.

Since you've received 80% or better on this quiz, you may claim continuing education credit.

You seem to have a popup blocker enabled. If you want to skip this dialog please Always allow popup windows for the online course.